GCM

Glenview Capital Management Portfolio holdings

AUM $5.49B Turnover 46.55%
1-Year Est. Return 46.89%
This Fund
S&P 500
This Quarter Est. Return
+20.53%
1 Year Est. Return
+46.89%
3 Year Est. Return
+94.27%
5 Year Est. Return
+129.04%
10 Year Est. Return
+529.98%
AUM
$11.4B
AUM Growth
+$1.92B
Cap. Flow
+$72.7M
Cap. Flow %
0.64%
Top 10 Hldgs %
54.72%
Holding
60
New
10
Increased
16
Reduced
21
Closed
10
Avg Time Held
2.2 years
Top 10 Avg Time Held
1.3 years
Top 20 Avg Time Held
1.8 years

Top Buys

Rank Stock Value
1
PARA icon
Paramount Global Class B
PARA
+$424M
2
BA icon
Boeing
BA
+$148M
3
COR icon
Cencora
COR
+$97.4M
4
CTVA icon
Corteva
CTVA
+$92.7M
5
HOLX icon
Hologic
HOLX
+$92.4M

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$175M
2
HUM icon
Humana
HUM
+$171M
3
FMC icon
FMC
FMC
+$116M
4
NXPI icon
NXP Semiconductors
NXPI
+$116M
5
LYB icon
LyondellBasell Industries
LYB
+$113M

Sector Composition

Rank Sector Weight
1 Healthcare 61.7%
2 Communication Services 12.02%
3 Technology 10.58%
4 Materials 5.99%
5 Industrials 4.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
HCA icon
1
HCA Healthcare
HCA
$101B
$882M 7.72%
5,964,853
+624,137
+12% +$83.8M
2013 Q2
26 quarters
CI icon
2
Cigna
CI
$76B
$854M 7.48%
4,176,524
-955,257
-19% -$175M
2013 Q2
26 quarters
THC icon
3
Tenet Healthcare
THC
$21.9B
$751M 6.57%
19,735,625
+261,540
+1% +$7.83M
2013 Q2
26 quarters
PARA icon
4
DELISTED
Paramount Global Class B
PARA
$633M 5.54%
15,080,758
+10,942,734
+264% +$424M
2013 Q2
26 quarters
TAK icon
5
Takeda Pharmaceutical
TAK
$60.6B
$603M 5.28%
30,582,721
+3,138,875
+11% +$60.1M
2019 Q1
3 quarters
IQV icon
6
IQVIA
IQV
$43.1B
$580M 5.07%
3,751,602
+133,905
+4% +$19.6M
2016 Q2
14 quarters
HOLX icon
7
DELISTED
Hologic
HOLX
$526M 4.6%
10,066,841
+1,856,654
+23% +$92.4M
2018 Q2
6 quarters
MCK icon
8
McKesson
MCK
$113B
$514M 4.5%
3,712,589
-292,029
-7% -$41.3M
2016 Q4
12 quarters
BHC icon
9
Bausch Health
BHC
$2.21B
$497M 4.35%
16,617,008
+2,806,494
+20% +$73M
2018 Q3
5 quarters
DXC icon
10
DXC Technology
DXC
$2.02B
$413M 3.61%
10,986,562
-809,770
-7% -$26.4M
2017 Q2
10 quarters
HUM icon
11
Humana
HUM
$51.3B
$388M 3.4%
1,059,787
-539,682
-34% -$171M
2018 Q4
4 quarters
FMC icon
12
FMC
FMC
$1.26B
$303M 2.65%
3,032,464
-1,251,368
-29% -$116M
2015 Q1
19 quarters
DIS icon
13
Walt Disney
DIS
$187B
$302M 2.64%
2,088,178
+211,242
+11% +$29.5M
2019 Q1
3 quarters
GOOGL icon
14
Alphabet (Google) Class A
GOOGL
$4.27T
$295M 2.58%
4,398,380
-10,300
-0.2% -$664K
2015 Q4
16 quarters
FLEX icon
15
Flex
FLEX
$37.5B
$257M 2.25%
26,989,848
+1,327,000
+5% +$11.4M
2013 Q2
26 quarters
NUAN
16
DELISTED
Nuance Communications, Inc.
NUAN
$244M 2.14%
13,698,118
+4,571,288
+50% +$75.8M
2018 Q3
5 quarters
CAR icon
17
Avis
CAR
$3.69B
$232M 2.03%
7,199,319
+2,873,849
+66% +$86.2M
2014 Q1
23 quarters
ELV icon
18
Elevance Health
ELV
$91.6B
$227M 1.99%
751,142
-116,885
-13% -$32.2M
2014 Q1
23 quarters
UNH icon
19
UnitedHealth
UNH
$349B
$223M 1.95%
757,121
+30,653
+4% +$8.02M
2019 Q2
2 quarters
FISV icon
20
Fiserv Inc
FISV
$24.4B
$206M 1.8%
1,782,886
-934,856
-34% -$103M
2019 Q3
1 quarter
COR icon
21
Cencora
COR
$63.7B
$204M 1.78%
2,397,318
+1,136,712
+90% +$97.4M
2018 Q1
7 quarters
MTOR
22
DELISTED
MERITOR, Inc.
MTOR
$189M 1.65%
7,207,435
– –
2013 Q2
26 quarters
WMB icon
23
Williams Companies
WMB
$89.7B
$186M 1.63%
7,844,612
+302,063
+4% +$6.92M
2016 Q2
14 quarters
DVA icon
24
DaVita
DVA
$11.5B
$144M 1.26%
1,914,754
-1,320,958
-41% -$87.6M
2019 Q1
3 quarters
LOW icon
25
Lowe's Companies
LOW
$105B
$143M 1.25%
1,193,686
+409,695
+52% +$46.8M
2016 Q4
12 quarters
1
2 3

Similar funds

GCM
Graham Capital Management Rowayton, Connecticut $5.5B AUM 26.66% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $5.49B AUM 56.94% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
MC
Maplelane Capital New York $5.51B AUM 67.92% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
NC
Nicholas Company Milwaukee, Wisconsin $5.47B AUM 16.96% 1-Year Est. Return
EI
EFG International Zurich $5.46B AUM
AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return

Glenview Capital Management's Q4 2019 Portfolio in Review

As of Q4 2019, Glenview Capital Management held 60 positions worth $11.4B, up 20% from $9.51B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Glenview Capital Management's Q4 2019 filing shows 10 new, 16 increased, 21 reduced and 10 closed positions. Its largest new stake was Boeing: 416,863 shares worth $136M. The largest sale was Cigna, an estimated $175M.

By sector, the portfolio is most concentrated in Healthcare at 62% of assets, down from 62% a quarter earlier, followed by Communication Services and Technology.

  • Glenview Capital Management's largest Q4 2019 buy was Boeing: 416,863 shares worth $136M.
  • Glenview Capital Management added most to Paramount Global Class B in Q4 2019, an estimated $424M increase.
  • Glenview Capital Management's biggest Q4 2019 reduction was Cigna, cutting an estimated $175M.
  • Glenview Capital Management fully exited NXP Semiconductors in Q4 2019, selling an estimated $116M.
  • Glenview Capital Management's ten largest holdings make up 55% of its $11.4B portfolio in Q4 2019.
  • Glenview Capital Management opened 10 new positions and closed 10 in Q4 2019.
  • Glenview Capital Management's portfolio value rose 20% quarter-over-quarter to $11.4B.

Based on Glenview Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.